Tilray joins in cash grab with $400 million debt sale as cannabis firms capitalize on euphoria Cannabis, Life Science
Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm Life Science
Cellular Bio Acquires Rights to Solid Tumor Immunotherapy from National Cancer Institute Life Science
Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer Life Science